Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (CAST) experience.
Am. J. Cardiol., Dec;78(11):1198-201 (1996)
Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
Am. Heart J., Feb;149(2):304-8 (2005)
Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
Pharmacotherapy., Nov;27(11):1558-70 (2007)
Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
Am. J. Cardiol., Oct;60(11):73F-78F (1987)
Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia.
Am. J. Cardiol., Jul;56(1):67-72 (1985)
Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location.
Am. J. Cardiol., Feb;61(4):224-9 (1988)
Surgical treatment of right atrial focal tachycardia in adults.
J. Am. Coll. Cardiol., May;11(5):1111-7 (1988)
Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
Am. J. Cardiol., Jul;66(1):68-74 (1990)
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
JAMA., Nov;270(20):2451-5 (1993)
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RA
Circulation., Sep;94(5):891-8 (1996)
The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.
N. Engl. J. Med., Dec;313(23):1444-9 (1985)
The clinical significance of ventricular arrhythmias after myocardial infarction.
Cardiol Clin., Feb;2(1):3-11 (1984)
Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.
Circulation., Apr;73(4):718-26 (1986)
Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (Ethmozine) in patients resistant to conventional antiarrhythmics.
Am. J. Med., Apr;80(4):626-32 (1986)
Hemodynamic effects of moricizine at rest and during supine bicycle exercise: results in patients with ventricular tachycardia and left ventricular dysfunction.
Am. Heart J., Jul;112(1):36-43 (1986)
Comparison of left ventricular diastolic function as determined by nuclear cardiac probe, radionuclide angiography, and contrast cineangiography.
J. Nucl. Med., Dec;27(12):1908-15 (1986)
Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
Am. J. Cardiol., Feb;59(4):278-83 (1987)
Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction.
Circulation., Apr;75(4):800-8 (1987)